logo Ibionextlogo Ibionext
  • HOME
  • ABOUT US
  • STRATEGY
  • TEAM
  • OUR COMPANIES
  • NEWS & MEDIA
  • CONTACT
  • Français
Twitter
LinkedIn

Using Medical Gaming to Monitor Chronic Eye Disease of Aging with Edouard Gasser Tilak Healthcare

January 27, 2021NewsIbionext

Edouard Gasser, CEO, Tilak Healthcare comes from the video gaming industry and is applying his knowledge about engaging mobile game players to an audience of those suffering from eye diseases of aging like AMD, age-related macular disease, or diabetic retinopathy.  Using the OdySight game prescribed by an ophthalmologist, patients are tracked to determine changes in vision through a medical module and puzzle game with data going back to the physician and patient with calls to action when necessary.

@TilakHealthcare #TilakHealthcare #OdySight #techforgood #ophthalmology

Listen to the Podcast here : https://empoweredpatientradio.com/using-medical-gaming-to-monitor-chronic-eye-disease-of-aging-with-edouard-gasser-tilak-healthcare

Tilakhealthcare.com

Download the transcript here

Previous post Digital health innovators share 2021 predictions Next post GML and DMP Partner to Showcase Virtual AI Sports Coach at docomo Open House

SEARCH

ARCHIVES

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

CATEGORIES

  • Events (3)
  • News (78)
  • Press releases (67)

LATEST NEWS

  • Théa partners with Tilak Healthcare to promote OdySight: First remote monitoring solution for ophthalmology June 29, 2022
  • GrAI Matter Labs Unveils Life-Ready AI with GrAI VIP at GLOBAL INDUSTRIE May 16, 2022
  • Rigshospitalet, the main hospital in Denmark based in Copenhagen, collaborate with Chronolife for a clinical investigation in Oncology March 31, 2022
  • Europrotect partners with Chronolife for the development and production of a device to measure physiological data, integrated into a firefighter’s intervention suit to limit the risk of thermal stress March 13, 2022
  • OdySight, first remote monitoring solution in ophthalmology to be reimbursed by the Social Security March 9, 2022

CONTACT US

74, rue du Faubourg Saint-Antoine 75012 Paris
+33 1 76 21 47 50
contact@ibionext.com

LEGAL NOTICES

  • Cookies Policy
  • Privacy Policy
  • Terms of use
© 2023 iBionext. All rights reserved